Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Katjana Orlopp"'
Autor:
Ernst Molitor, S M Reiffert, I Purr, Katjana Orlopp, Axel Glasmacher, Günter Marklein, Marcus Gorschlüter, Corinna Hahn-Ast, A Welter, M. von Lilienfeld-Toal
Publikováno v:
Journal of Antimicrobial Chemotherapy. 62:1109-1112
False-positive results of the galactomannan (GM) ELISA caused by concurrent administration of piperacillin/tazobactam have been reported in patients with febrile neutropenia.This prospective study investigated different sampling times in 30 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36d12be52abca1f0d4f4e06638c9fcde
https://doi.org/10.1093/jac/dkn308
https://doi.org/10.1093/jac/dkn308
Autor:
Corinna Hahn-Ast, Günter Marklein, Axel Glasmacher, A. Arns, Katjana Orlopp, A. Mühling, M. von Lilienfeld-Toal
Publikováno v:
Infection. 36:54-58
Glycopeptides are often used for persistent fever in neutropenic patients. This study compares efficacy and toxicity of teicoplanin and vancomycin. Hundred consecutive neutropenic patients with hematological malignancies and persistent fever after 72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c45992c303100258a39e48564dfd2dc
https://doi.org/10.1007/s15010-007-7126-4
https://doi.org/10.1007/s15010-007-7126-4
CD4+ T lymphocyte counts after autologous transplantation in multiple myeloma: A retrospective study
Autor:
Ulrich Mey, Ingo G.H. Schmidt-Wolf, Katjana Orlopp, Axel Glasmacher, Susann Sarazin, Frank Hackbarth, Marcus Gorschlüter, Eckfried Hoebert
Publikováno v:
Leukemia & Lymphoma. 48:506-512
The risk for opportunistic infections is correlated with low CD4+ T lymphocyte counts in patients with HIV. We performed a retrospective analysis in 54 patients with multiple myeloma undergoing high-dose melphalan chemotherapy + autologous peripheral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee3ee98ad368069d92aa607a3185bca5
https://doi.org/10.1080/10428190601094347
https://doi.org/10.1080/10428190601094347
Autor:
John Strehl, Attilio Olivieri, Marcus Gorschlueter, Manfred Hensel, Ulrich Mey, Axel Glasmacher, Christian Rabe, Dimitri Flieger, Katjana Orlopp, Ingo G.H. Schmidt-Wolf
Publikováno v:
Leukemia & Lymphoma. 47:2558-2566
The addition of rituximab to chemotherapy in patients with diffuse large B-cell lymphoma (DLBCL) has been shown to improve outcome in first-line therapy. However, in patients with relapsed or refractory disease, the value of adding rituximab to salva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6549d0f7958139840833f610a4641be7
https://doi.org/10.1080/10428190600926572
https://doi.org/10.1080/10428190600926572
Autor:
Hendrik Pels, Uwe Schlegel, Alexander Semmler, Ingo G.H. Schmidt-Wolf, Horst Urbach, Marlies Vogt-Schaden, Katjana Orlopp, Annika Jürgens, Matthias Simon, Michael Linnebank, Axel Glasmacher, Susanna Moskau, Christopher Bangard
Methotrexate (MTX) is an important anticancer drug and the most efficient chemotherapy component in primary CNS lymphoma (PCNSL). A typical side effect of intravenous high-dose MTX is the occurrence of confluent CNS white matter changes (WMC). Becaus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf39915996e1d802c2ffcfe7f443a1f8
https://www.zora.uzh.ch/id/eprint/5562/
https://www.zora.uzh.ch/id/eprint/5562/
Autor:
Axel Glasmacher, Axel Florschütz, Katjana Orlopp, Marcus Gorschlüter, Josef Birkmann, Christian Rabe, Ingo G.H. Schmidt-Wolf, Ulrich Mey, Dimitri Flieger, Manfred Hensel, Anthony D. Ho, C. Hahn, Andreas Neubauer, John Strehl, Ulrich Kaiser, Cordula Bopp, Martin Wilhelm
Publikováno v:
Cancer investigation. 24(6)
We designed a multicenter Phase II trial to prospectively evaluate the efficacy and safety of the combination of rituximab with the DHAP regimen (dexamethasone, high-dose cytarabine, cisplatin) in patients who relapsed after or were resistant to a CH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdab521dbc2cab2a05c72581eea12cc2
https://pubmed.ncbi.nlm.nih.gov/16982464
https://pubmed.ncbi.nlm.nih.gov/16982464
Autor:
Katjana Orlopp, Marie von Lilienfeld-Toal, Hartmut Goldschmidt, Ralph Naumann, Ingo G.H. Schmidt-Wolf, Florian Hoffmann, Marcus Gorschlüter, C. Hahn, Axel Glasmacher
Publikováno v:
British journal of haematology. 132(5)
The activity of thalidomide in relapsed or refractory multiple myeloma is widely accepted but not yet demonstrated in a randomised-controlled trial. A systematic review of the published clinical trials of these patients could reduce the possible bias
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f0283e0f13342e73a73c916dacb8c7
https://pubmed.ncbi.nlm.nih.gov/16445831
https://pubmed.ncbi.nlm.nih.gov/16445831
Publikováno v:
Archiv fur Kriminologie. 210(5-6)
The retrospective analysis of the autopsy records of 50 homicides showed that the Injury Severity Score (ISS), a numerical scoring system initially developed to quantify the severity of injuries sustained in road traffic accidents, can also be useful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::436a5d2ad5c9d1f71e379886ebff0fda
https://pubmed.ncbi.nlm.nih.gov/12532680
https://pubmed.ncbi.nlm.nih.gov/12532680
Autor:
Corinna Hahn-Ast, Marie von Lilienfeld-Toal, Katjana Orlopp, Glasmacher Axel, Schmidt-Wolf G.H. Ingo
Publikováno v:
Blood. 108:4570-4570
Elderly (>55 years) patients with relapsed acute myeloid leukemia (AML) generally have a poor prognosis mainly due to a low rate of 2nd complete remission (CR). Commonly, salvage therapy consists of regimens including fludarabine. However, results ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2db6ceede772bffcb54d33871acb389b
https://doi.org/10.1182/blood.v108.11.4570.4570
https://doi.org/10.1182/blood.v108.11.4570.4570
Publikováno v:
Bone. 38:73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c51854bda6ed0398b9520813a1101483
https://doi.org/10.1016/j.bone.2006.01.024
https://doi.org/10.1016/j.bone.2006.01.024